Real-time enrollment status for this kidney disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06740526 |
| Recruiting Status | Recruiting |
| Condition | Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 25 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | April 6, 2025 (Apr 6, 2025) |
As of March 2, 2026: Clinical trial NCT06740526 is currently recruiting participants. This clinical trial study for kidney disease is actively seeking new participants at 4 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06740526 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06740526 was last updated Apr 6, 2025 (April 6, 2025). HelloStudys verifies this status automatically.